The Times

.

GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae

BANGALORE, INDIA / SINGAPORE - Media OutReach Newswire - 23 December 2024 - GangaGen announced today that it has secured the third instalment of its phased funding grant from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), the global initiative led by Boston University to support the development of antibacterial products aimed at diagnosing, preventing, and treating drug-resistant infections.


Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 18

Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 2 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 3 in /httpdocs/templates/gk_university/html/pagination.php on line 34
hacklink hack forum hacklink film izle hacklink makrobetperabetgamdomonline casinos australiaonwinonline casino australiaDeneme bonusu veren siteler 2026Meritbetjojobet girişjojobetgrandpashabetbetparklove marketim1Red casinojojobetjojobet güncel girişjojobet girişjojobetmeritkingbets10slot siteleriเว็บสล็อตเว็บสล็อตmix parlaydeneme bonusu veren sitelerjojobetgrandpashabetcasibomholiganbetjojobetgrandpashabetcasibomholiganbet